alendronate has been researched along with Femur Neck Fractures in 16 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with once-weekly 70 mg alendronate significantly improved the BMD at the lumbar spine and femoral neck in patients with prostate cancer with severe osteopenia or osteoporosis and on ADT, and significantly decreased the risk of femoral neck fracture." | 7.75 | Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis. ( Cecchini, L; Encabo, G; Morote, J; Orsola, A; Placer, J; Planas, J; Raventós, C; Salvador, C; Trilla, E, 2009) |
| "Treatment with once-weekly 70 mg alendronate significantly improved the BMD at the lumbar spine and femoral neck in patients with prostate cancer with severe osteopenia or osteoporosis and on ADT, and significantly decreased the risk of femoral neck fracture." | 3.75 | Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis. ( Cecchini, L; Encabo, G; Morote, J; Orsola, A; Placer, J; Planas, J; Raventós, C; Salvador, C; Trilla, E, 2009) |
| "Because on bone marker measurement bone resorption was increased and bone formation was decreased from baseline, treatment was switched to oral alendronate (5 mg/day, daily)." | 1.31 | Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report. ( Iwamoto, J; Takeda, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peake, C | 1 |
| Trompeter, A | 1 |
| Ji, WP | 1 |
| Wang, XL | 1 |
| Ma, MQ | 1 |
| Lan, J | 1 |
| Li, H | 1 |
| Bryson, DJ | 1 |
| Nichols, JS | 1 |
| Ford, AJ | 1 |
| Williams, SC | 1 |
| Chen, JS | 1 |
| Chen, PM | 1 |
| Lin, CY | 1 |
| Chen, RF | 1 |
| Lee, PY | 1 |
| Planas, J | 1 |
| Trilla, E | 1 |
| Raventós, C | 1 |
| Cecchini, L | 1 |
| Orsola, A | 1 |
| Salvador, C | 1 |
| Placer, J | 1 |
| Encabo, G | 1 |
| Morote, J | 1 |
| Curtis, JR | 1 |
| Delzell, E | 1 |
| Chen, L | 1 |
| Black, D | 1 |
| Ensrud, K | 1 |
| Judd, S | 1 |
| Safford, MM | 1 |
| Schwartz, AV | 1 |
| Bauer, DC | 1 |
| Rebolledo, BJ | 1 |
| Unnanuntana, A | 1 |
| Lane, JM | 1 |
| Donaldson, MG | 1 |
| Palermo, L | 1 |
| Ensrud, KE | 1 |
| Hochberg, MC | 1 |
| Schousboe, JT | 1 |
| Cummings, SR | 1 |
| Robinson, PJ | 1 |
| Bell, RJ | 1 |
| Lanzafame, A | 1 |
| Segal, L | 1 |
| Kirby, C | 1 |
| Piterman, L | 1 |
| Davis, SR | 1 |
| Iwamoto, J | 1 |
| Takeda, T | 1 |
| Harada, A | 1 |
| Levenets', VM | 1 |
| Kharytonov, OD | 1 |
| Pohodaieva, AV | 1 |
| Kishimoto, H | 1 |
| Inaba, M | 1 |
| Dempster, DW | 1 |
4 reviews available for alendronate and Femur Neck Fractures
| Article | Year |
|---|---|
[Evidence of alendronate treatment for osteoporosis].
Topics: Alendronate; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Density Conservation Agents; Colla | 2007 |
[Bisphosphonates: pharmacology and use in the treatment of osteoporosis].
Topics: Alendronate; Bone Density; Bone Remodeling; Clinical Trials as Topic; Diphosphonates; Etidronic Acid | 2002 |
[Alendronate in the treatment of osteoporosis].
Topics: Alendronate; Bone Density; Bone Resorption; Clinical Trials as Topic; Femoral Neck Fractures; Fractu | 2002 |
The impact of bone turnover and bone-active agents on bone quality: focus on the hip.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Remodeling; Femoral Neck Fractures; Femur N | 2002 |
3 trials available for alendronate and Femur Neck Fractures
| Article | Year |
|---|---|
The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Confounding Factors, Epidemiologic; Diphosphonat | 2011 |
Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Confidence Int | 2012 |
Comparison of plain vertebral X-ray and dual-energy X-ray absorptiometry for the identification of older women for fracture prevention in primary care.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Australia; Bone Density; Bone Density | 2013 |
9 other studies available for alendronate and Femur Neck Fractures
| Article | Year |
|---|---|
Low-energy atypical femoral shaft and ipsilateral neck fracture: a rare association.
Topics: Aftercare; Aged; Alendronate; Bone Density Conservation Agents; Bone Plates; Bone Screws; Denosumab; | 2017 |
Prevention of early bone loss around the prosthesis by administration of anti-osteoporotic agents and influences of collared and non-collared femoral stem prostheses on early periprosthetic bone loss.
Topics: Absorptiometry, Photon; Aged; Alendronate; Arthroplasty, Replacement, Hip; Bone Density; Bone Densit | 2013 |
The incidence of vitamin D deficiency amongst patients with a femoral neck fracture: are current bone protection guidelines sufficient ?
Topics: Accidental Falls; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Female; Fe | 2013 |
Beneficial effects of bipolar hemiarthroplasty replacement and fosamax in the retrospective cohort study of refracture and mortality of hip fractured patients.
Topics: Aged; Alendronate; Arthroplasty, Replacement, Hip; Bone Density; Bone Density Conservation Agents; C | 2016 |
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
Topics: Absorptiometry, Photon; Aged; Alendronate; Androgen Antagonists; Bone Density; Bone Density Conserva | 2009 |
Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report.
Topics: Accidental Falls; Adenine; Alendronate; Anti-HIV Agents; Bone Density Conservation Agents; Comorbidi | 2011 |
Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report.
Topics: Administration, Oral; Aged; Alendronate; Bone Density; Bone Resorption; Dose-Response Relationship, | 2002 |
[Alendronate (Fosamax 10 mg). The first amino-biphosphate for the treatment of women with postmenopausal osteoporosis].
Topics: Aged; Alendronate; Diphosphonates; Dose-Response Relationship, Drug; Female; Femoral Neck Fractures; | 1996 |
[Fracture of the femoral neck and osteoporosis].
Topics: Age Factors; Aged; Aged, 80 and over; Alendronate; Analgesics; Calcitonin; Calcium, Dietary; Femoral | 1997 |